D
Ventyx Biosciences, Inc. VTYX
$7.94 -$1.44-15.35% NASDAQ
Recommendation
Prev Close
$9.38
Volume
4,610,484
Avg Vol (90D)
3,087,070
Market Cap
$669.34M
Dividend & Yield
--
52-Week Range
$0.78 - $10.55
P/E (TTM)
--
EPS (TTM)
-$1.50
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Ventyx Biosciences (NASDAQ:VTYX) Shares Gap Down - Should You Sell?
12/2/2025 - Ticker Report
Ventyx Biosciences (VTYX, $9.38) Aroon Indicator entered an Uptrend on December 01, 2025.
12/2/2025 - Tickeron - Stocks
Ventyx Biosciences provides update on ongoing Phase 2 study of VTX2735
12/2/2025 - The Fly
Ventyx Biosciences appoints Mark McKenna as strategic advisor
12/2/2025 - The Fly
Ventyx Provides Clinical and Corporate Updates
12/2/2025 - Globe Newswire
Institutional owners may ignore Ventyx Biosciences, Inc.'s (NASDAQ:VTYX) recent US$77m market cap decline as longer-term profits stay in the green
12/2/2025 - Simply Wall St
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of "Moderate Buy" from Brokerages
12/2/2025 - MarketBeat
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
12/1/2025 - GuruFocus
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
12/1/2025 - Globe Newswire
Ventyx Biosciences (VTYX, $10) Aroon Indicator entered an Uptrend on November 28, 2025.
11/29/2025 - Tickeron - Technical Analysis
Ventyx Biosciences (VTYX, $9.99) RSI Indicator left the overbought zone on November 26, 2025
11/27/2025 - Tickeron - Technical Analysis
Ventyx Biosciences (VTYX, $9.99) Aroon Indicator entered an Uptrend on November 26, 2025.
11/27/2025 - Tickeron - Technical Analysis
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 1-Year High - Time to Buy?
11/27/2025 - MarketBeat
Ventyx Biosciences (VTYX, $10.46) price may drop as it broke higher Bollinger Band on Nov 25, 2025
11/26/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX, $10.46) Aroon Indicator entered an Uptrend on November 25, 2025.
11/26/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX, $9.95) Aroon Indicator entered an Uptrend on November 24, 2025.
11/25/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX, $9.95) RSI Indicator left the overbought zone on November 24, 2025
11/25/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX) Outlook Strengthened by Cost Optimization and Positive Clinical Data
11/23/2025 - Insider Monkey
Ventyx Biosciences (VTYX, $9.43) Aroon Indicator entered an Uptrend on November 21, 2025.
11/22/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX, $9.43) RSI Indicator left the overbought zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 12-Month High - Time to Buy?
11/21/2025 - MarketBeat
Ventyx Biosciences (VTYX, $9.61) RSI Indicator left the overbought zone on November 20, 2025
11/21/2025 - Tickeron - Stocks
Ventyx Biosciences (VTYX, $9.61) Aroon Indicator entered an Uptrend on November 20, 2025.
11/21/2025 - Tickeron - Stocks
Ventyx Biosciences (NASDAQ:VTYX) Reaches New 12-Month High - Time to Buy?
11/20/2025 - Ticker Report
Ventyx Biosciences (VTYX, $9.47) RSI Indicator left the overbought zone on November 19, 2025
11/20/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$116.44M
EBIT (TTM)
-$116.72M
Net Income (TTM)
-$106.61M
Balance Sheet
Total Assets (Q)
$211.47M
Total Debt (Q)
$10.02M
Total Liabilities (Q)
$20.10M
Book Value Per Share (Q)
$2.68
Cash Flow
Cash from Operations (TTM)
-$87.75M
Cash from Investing (TTM)
$57.66M
Cash from Financing (TTM)
$246.00K
Net Change in Cash (TTM)
-$29.80M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.94
7-Day Total Return
-17.38%
30-Day Total Return
114.02%
60-Day Total Return
233.61%
90-Day Total Return
149.69%
Year to Date Total Return
271.03%
1-Year Total Return
215.08%
2-Year Total Return
262.56%
3-Year Total Return
-72.60%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $0.78
52-week High
Nov 26, 2025 - $10.55
Valuation
Market Cap
$669.34M - Small Cap
Enterprise Value
$486.73M
Price/Sales (TTM)
--
Price/Book (Q)
3.50
Dividends and Shares
Shares Outstanding
71.30
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
ventyxbio.com
Phone Number
760 593 4832
Address
12790 El Camino Real
San Diego, CA 92130
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company’s lead... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed